INDBInternet News Database 2.5 Updated 2 min ago · 397 sources Show or hide images Light or dark

FDA Okays Once-Weekly Tx for Turner Syndrome Growth Failure

Save Like Comments Compare coverage

Summary

The long-acting injectable growth hormone somapacitan-beco is also approved for other growth deficiencies in adults and children.

Description from Medscape.

Who is covering this

  1. Medscape Center Factuality: Mostly factual US
    FDA Okays Once-Weekly Tx for Turner Syndrome Growth Failure

    The long-acting injectable growth hormone somapacitan-beco is also approved for other growth deficiencies in adults and children.

Comments

Comments need JavaScript.